Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Gains from Investment Securities (2016 - 2025)

InfuSystem Holdings (INFU) has disclosed Gains from Investment Securities for 15 consecutive years, with -$1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities rose 55.39% year-over-year to -$1.2 million, compared with a TTM value of -$114000.0 through Dec 2025, up 94.16%, and an annual FY2025 reading of -$114000.0, up 94.16% over the prior year.
  • Gains from Investment Securities was -$1.2 million for Q4 2025 at InfuSystem Holdings, down from $578000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.6 million in Q4 2023 and bottomed at -$2.6 million in Q4 2024.
  • Average Gains from Investment Securities over 5 years is $162947.4, with a median of $324000.0 recorded in 2023.
  • Peak annual rise in Gains from Investment Securities hit 57700.0% in 2025, while the deepest fall reached 299.73% in 2025.
  • Year by year, Gains from Investment Securities stood at $31000.0 in 2021, then surged by 1496.77% to $495000.0 in 2022, then soared by 231.52% to $1.6 million in 2023, then plummeted by 257.1% to -$2.6 million in 2024, then skyrocketed by 55.39% to -$1.2 million in 2025.
  • Business Quant data shows Gains from Investment Securities for INFU at -$1.2 million in Q4 2025, $578000.0 in Q3 2025, and $1.2 million in Q2 2025.